Escitalopram
136 interactions 7 explained in plain English
Also sold as:
Lexapro
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Linezolid Injection
Metoclopramide Nasal Spray
Metoclopramide Injection
Palonosetron Injection
Flurbiprofen
Degarelix Injection
Contraindicated
Escitalopram Linezolid Injection Zyvox An increased risk of serotonin syndrome Details Escitalopram Metoclopramide Injection Gimoti An increased risk of extrapyramidal reactions and neuroleptic malignant syndrome Details Escitalopram Metoclopramide Nasal Spray Gimoti An increased risk of extrapyramidal reactions and neuroleptic malignant syndrome DetailsMajor
Escitalopram Acetaminophen And Codeine Capital® & Codeine Explained Increased risk of serotonin syndrome, increased codeine exposure and reduced active metabolite (morphine) exposure Details Escitalopram Omeprazole Gastrobim Explained Increased escitalopram exposure Details Escitalopram Amitriptyline Elavil Explained An increased risk of QT interval prolongation, an increased risk of serotonin syndrome and increased CYP2D6 substrate exposure Details Escitalopram Sertraline Explained Increased risk of serotonin syndrome and an increased risk of QT interval prolongation Details Escitalopram Buprenorphine Belbuca Explained An increased risk of QT interval prolongation and an increased risk of serotonin syndrome Details Escitalopram Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Escitalopram Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Escitalopram Apixaban Eliquis Explained An increased risk of bleeding and can cause serious, potentially fatal bleeding Details Escitalopram Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Escitalopram Aripiprazole Injection Abilify An increased risk of QT interval prolongation and increased CYP2D6 substrate exposure Details Escitalopram Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Escitalopram Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Escitalopram Aspirin Acuprin® An increased risk of bleeding Details Escitalopram Aspirin Rectal Aspirin An increased risk of bleeding Details Escitalopram Azathioprine Azasan An increased risk of hepatotoxicity Details Escitalopram Azithromycin AzaSite An increased risk of QT interval prolongation Details Escitalopram Betrixaban Bevyxxa® An increased risk of bleeding Details Escitalopram Alfuzosin UroXatral An increased risk of QT interval prolongation Details Escitalopram Anagrelide Agrylin An increased risk of QT interval prolongation and an increased risk of bleeding Details Escitalopram Bedaquiline Sirturo An increased risk of QT interval prolongation Details Escitalopram Brexpiprazole Rexulti Increased brexpiprazole exposure Details Escitalopram Bromfenac Ophthalmic Bromday® An increased risk of bleeding Details Escitalopram Butorphanol Injection Butorphic Increased risk of serotonin syndrome Details Escitalopram Butorphanol Nasal Spray Stadol® NS Increased risk of serotonin syndrome Details Escitalopram Chloroquine Aralen® An increased risk of QT interval prolongation Details Escitalopram Clopidogrel Plavix An increased risk of bleeding Details Escitalopram Dabigatran Pradaxa® An increased risk of bleeding Details Escitalopram Dabigatran Etexilate An increased risk of bleeding Details Escitalopram Dalteparin Injection Fragmin An increased risk of bleeding Details Escitalopram Dasatinib Phyrago An increased risk of QT interval prolongation Details Escitalopram Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Escitalopram Deutetrabenazine Austedo An increased risk of QT interval prolongation and increased CYP2D6 substrate exposure Details Escitalopram Diclofenac Ophthalmic Voltaren® Eye Drops An increased risk of bleeding Details Escitalopram Diclofenac Topical (Actinic Keratosis) Pennsaid An increased risk of bleeding Details Escitalopram Diclofenac Topical (Arthritis Pain) Pennsaid® An increased risk of bleeding Details Escitalopram Diclofenac Transdermal Patch Flector An increased risk of bleeding Details Escitalopram Dipyridamole Permole® An increased risk of bleeding DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.